Heterogeneous memory T cells in antiviral immunity and immunopathology

Viral Immunology

Volumn 21, Issue 2, 2008, Pages 99-113

  Verhoeven, David ^a   Teijaro, John R ^a   Farber, Donna L ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL HETEROGENEITY; CELL PROTECTION; CONFERENCE PAPER; CYTOKINE PRODUCTION; DOWN REGULATION; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; LYMPHOCYTE SUBPOPULATION; MEMORY T LYMPHOCYTE; PHENOTYPE; TELOMERE; TISSUE DISTRIBUTION; VIRUS IMMUNITY; VIRUS INFECTION;

ANIMALS; HUMANS; IMMUNOLOGIC MEMORY; T-LYMPHOCYTE SUBSETS; VIRUS DISEASES; VIRUSES;

EID: 45749121896     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2007.0002     Document Type: Conference Paper

References (169)

1. Abate G, Eslick J, Newman FK, Frey SE, Belshe RB, Monath TP, and Hoft DF: Flow-cytometric detection of vaccinia-induced memory effector CD4(+), CD8(+), and gamma delta TCR(+) T cells capable of antigen-specific expansion and effector functions. J Infect Dis 2005;192:1362-1371.
2. Acosta-Rodriguez EV, Rivino L, Geginat J, et al.: Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007;8:639-646.
3. Adams AB, Williams MA, Jones TR, et al.: Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003;111:1887-1895.
4. Ahmadzadeh M, and Farber DL: Functional plasticity of an antigen-specific memory CD4 T cell population. Proc Natl Acad Sci USA 2002;99:11802-11807.
5. Ahmadzadeh M, Hussain SF, and Farber DL: Effector CD4 T cells are biochemically distinct from the memory subset: evidence for long-term persistence of effectors in vivo. J Immunol 1999;163:3053-3063.
6. Ahmadzadeh M, Hussain SF, and Farber DL: Heterogeneity of the memory CD4 T cell response: persisting effectors and resting memory T cells. J Immunol 2001;166:926-935.
7. Ahmed R, Oldstone MB, and Palese P: Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic. Nat Immunol 2007;8:1188-1193.
8. Alimonti JB, Ball TB, and Fowke KR: Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS. J Gen Virol 2003;84:1649-1661.
9. Annunziato F, Cosmi L, Vantarlasci V, et al.: Phenotypic and functional features of human Th17 cells. J Exp Med 2007;204:1849-1861.
10. Antonis AF, Claassen EA, Hensen EJ, de Groot RJ, de Groot-Mijnes JD, Schrijver RS, and van der Most RG: Kinetics of antiviral CD8 T cell responses during primary and post-vaccination secondary bovine respiratory syncytial virus infection. Vaccine 2006;24:1551-1561.
11. Bachmann MF, Kundig TM, Hengartner H, and Zinkernagel RM: Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"? Proc Natl Acad Sci USA 1997;94:640-645.
12. Bachmann MF, Wolint P, Schwarz K, Jager P, and Oxenius A: Functional properties and lineage relationship of CD8+ T cell subsets identified by expression of IL-7 receptor alpha and CD62L. J Immunol 2005;175:4686-4696.
13. Badovinac VP, Haring JS, and Harty JT: Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8(+) T cell response to infection. Immunity 2007;26:827-841.
14. Becker TC, Coley SM, Wherry EJ, and Ahmed R: Bone marrow is a preferred site for homeostatic proliferation of memory CD8 T cells. J Immunol 2005;174:1269-1273.
15. Bertram EM, Tafuri A, Shahinian A, et al.: Role of ICOS versus CD28 in antiviral immunity. Eur J Immunol 2002;32:3376-3385.
16. Bingaman AW, Patke DS, Mane VR, Ahmadzadeh M, Ndejembi M, Bartlett ST, and Farber DL: Novel phenotypes and migratory properties distinguish memory CD4 T cell subsets in lymphoid and lung tissue. Eur J Immunol 2005;35:3173-3186.
17. Borowski AB, Boesteanu AC, Mueller YM, et al.: Memory CD8+ T cells require CD28 costimulation. J Immunol 2007;179:6494-6503.
18. Borst J, Hendriks J, and Xiao Y: CD27 and CD70 in T cell and B cell activation. Curr Opin Immunol 2005;17:275-281.
19. Bottomly K, Luqman M, Greenbaum L, Carding S, West J, Pasqualini T, and Murphy DB: A monoclonal antibody to murine CD45R distinguishes CD4 T cell populations that produce different cytokines. Eur J Immunol 1989;19:617-623.
20. Brenchley JM, Price DA, and Douek DC: HIV disease: fallout from a mucosal catastrophe? Nat Immunol 2006;7:235-239.
21. Bruder D, Srikiatkhachorn A, and Enelow RI: Cellular immunity and lung injury in respiratory virus infection. Viral Immunol 2006;19:147-155.
22. Budd RC, Cerottini JC, Horvath C, Bron C, Pedrazzini T, Howe RC, and MacDonald HR: Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation. J Immunol 1987;138:3120-3129.
23. Casazza JP, Betts MR, Price DA, et al.: Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation. J Exp Med 2006;203:2865-2877.
24. Cauley LS, Cookenham T, Miller TB, Adams PS, Vignali KM, Vignali DA, and Woodland DL: Cutting edge: virus-specific CD4+ memory T cells in nonlymphoid tissues express a highly activated phenotype. J Immunol 2002;169:6655-6658.
25. Champagne P, Ogg GS, King AS, et al.: Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001;410:106-111.
26. Chandok MR, and Farber DL: Signaling control of memory T cell generation and function. Semin Immunol 2004;16:285-293.
27. Chen HD, Fraire AE, Joris I, Brehm MA, Welsh RM, and Selin LK: Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. Nat Immunol 2001;2:1067-1076.
28. Choi J, Enis DR, Koh KP, Shiao SL, and Pober JS: T lymphocyte-endothelial cell interactions. Annu Rev Immunol 2004;22:683-709.
29. Christensen JP, Cardin RD, Branum KC, and Doherty PC: CD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma. Proc Natl Acad Sci USA 1999;96:5135-5140.
30. Cohavy O, Zhou J, Ware CF, and Targan SR: LIGHT is constitutively expressed on T and NK cells in the human gut and can be induced by CD2-mediated signaling. J Immunol 2005;174:646-653.
31. Croft M, Bradley LM, and Swain SL: Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J Immunol 1994;152:2675-2685.
32. Dandekar S: Pathogenesis of HIV in the gastrointestinal tract. Curr HIV/AIDS Rep 2007;4:10-15.
33. Darrah PA, Patel DT, De Luca PM, et al.: Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 2007;13:843-850.
34. de Bree GJ, van Leeuwen EM, Out TA, Jansen HM, Jonkers RE, and van Lier RA: Selective accumulation of differentiated CD8+ T cells specific for respiratory viruses in the human lung. J Exp Med 2005;202:1433-1442.
35. Debes GF, Bonhagen K, Wolff T, Kretschmer U, Krautwald S, Kamradt T, and Hamann A: CC chemokine receptor 7 expression by effector/memory CD4+ T cells depends on antigen specificity and tissue localization during influenza A virus infection. J Virol 2004;78:7528-7535.
36. Debes GF, Hopken UE, and Hamann A: In vivo differentiated cytokine-producing CD4(+) T cells express functional CCR7. J Immunol 2002;168:5441-5447.
37. Dengler TJ, and Pober JS: Human vascular endothelial cells stimulate memory but not naive CD8+ T cells to differentiate into CTL retaining an early activation phenotype. J Immunol 2000;164:5146-5155.
38. Di Fabio S, Mbawuike IN, Kiyono H, Fujihashi K, Couch RB, and McGhee JR: Quantitation of human influenza virus-specific cytotoxic T lymphocytes: correlation of cytotoxicity and increased numbers of IFN-gamma producing CD8+ T cells. Int Immunol 1994;6:11-19.
39. Doherty PC, Turner SJ, Webby RG, and Thomas PG: Influenza and the challenge for immunology. Nat Immunol 2006;7:449-455.
40. Ebert EC: CD2 activation of human lamina propria lymphocytes reduces CD3 responsiveness. Immunology 2006;117:71-77.
41. Ely KH, Cookenham T, Roberts AD, and Woodland DL: Memory T cell populations in the lung airways are maintained by continual recruitment. J Immunol 2006;176:537-543.
42. Ely KH, Roberts AD, and Woodland DL: Cutting edge: effector memory CD8+ T cells in the lung airways retain the potential to mediate recall responses. J Immunol 2003;171:3338-3342.
43. Ennis FA, Meager A, Beare AS, et al.: Interferon induction and increased natural killer-cell activity in influenza infections in man. Lancet 1981;2:891-893.
44. Farber DL: Differential TCR signaling and the generation of memory T cells. J Immunol 1998;160:535-539.
45. Flynn KJ, Belz GT, Altman JD, Ahmed R, Woodland DL, and Doherty PC: Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 1998;8:683-691.
46. Fritsch RD, Shen X, Sims GP, Hathcock KS, Hodes RJ, and Lipsky PE: Stepwise differentiation of CD4 memory T cells defined by expression of CCR7 and CD27. J Immunol 2005;175:6489-6497.
47. Gagnon SJ, Ennis FA, and Rothman AL: Bystander target cell lysis and cytokine production by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones. J Virol 1999;73:3623-3629.
48. Goldstein I, Ben-Horin S, Li J, Bank I, Jiang H, and Chess L: Expression of the α1β integrin, VLA-1, marks a distinct subset of human CD4+ memory T cells. J Clin Invest 2003;112:1444-1454.
49. Guadalupe M, Reay E, Sankaran S, Prindiville T, Flamm J, McNeil A, and Dandekar S: Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 2003;77:11708-11717.
50. Harari A, Dutoit V, Cellerai C, Bart PA, Du Pasquier RA, and Pantaleo G: Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunol Rev 2006;211:236-254.
51. He XS, Holmes TH, Zhang C, et al.: Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J Virol 2006;80:11756-11766.
52. Heller KN, Upshaw J, Seyoum B, Zebroski H, and Munz C: Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers. Blood 2007;109:1138-1146.
53. Hikono H, Kohlmeier JE, Takamura S, Wittmer ST, Roberts AD, and Woodland DL: Activation phenotype, rather than central- or effector-memory phenotype, predicts the recall efficacy of memory CD8+ T cells. J Exp Med 2007;204:1625-1636.
54. Hildeman D, Yanez D, Pederson K, Havighurst T, and Muller D: Vaccination against persistent viral infection exacerbates CD4+ T-cell-mediated immunopathological disease. J Virol 1997;71:9672-9678.
55. Hogan RJ, Cauley LS, Ely KH, et al.: Long-term maintenance of virus-specific effector memory CD8+ T cells in the lung airways depends on proliferation. J Immunol 2002;169:4976-4981.
56. Hogan RJ, Usherwood EJ, Zhong W, Roberts AA, Dutton RW, Harmsen AG, and Woodland DL: Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections. J Immunol 2001;166:1813-1822.
57. Hogan RJ, Zhong W, Usherwood EJ, Cookenham T, Roberts AD, and Woodland D: Protection from respiratory virus infections can be mediated by antigen-specific CD4(+) T cells that persist in the lungs. J Exp Med 2001;193:981-986.
58. Humphreys IR, Walzl G, Edwards L, Rae A, Hill S, and Hussell T: A critical role for OX40 in T cell-mediated immunopathology during lung viral infection. J Exp Med 2003;198:1237-1242.
59. Jelley-Gibbs DM, Brown DM, Dibble JP, Haynes L, Eaton SM, and Swain SL: Unexpected prolonged presentation of influenza antigens promotes CD4 T cell memory generation. J Exp Med 2005;202:697-706.
60. Kaech SM, Wherry EJ, and Ahmed R: Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2002;2:251-262.
61. Kaiserlian D, Cerf-Bensussan N, and Hosmalin A: The mucosal immune system: from control of inflammation to protection against infections. J Leukoc Biol 2005;78:311-318.
62. Kassiotis G, Gray D, Kiafard Z, Zwirner J, and Stockinger B: Functional specialization of memory Th cells revealed by expression of integrin CD49b. J Immunol 2006;177:968-975.
63. Kedzierska K, Stambas J, Jenkins MR, Keating R, Turner SJ, and Doherty PC: Location rather than CD62L phenotype is critical in the early establishment of influenza-specific CD8+ T cell memory. Proc Natl Acad Sci USA 2007;104:9782-9787.
64. Kim SK, Schluns KS, and Lefrancois L: Induction and visualization of mucosal memory CD8 T cells following systemic virus infection. J Immunol 1999;163:4125-4132.
65. Kivisakk P, Mahad DJ, Callahan MK, et al.: Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc Natl Acad Sci USA 2003;100:8389-8394.
66. Klonowski KD, Marzo AL, Williams KJ, Lee SJ, Pham QM, and Lefrancois L: CD8 T cell recall responses are regulated by the tissue tropism of the memory cell and pathogen. J Immunol 2006;177:6738-6746.
67. Klonowski KD, Williams KJ, Marzo AL, Blair DA, Lingenheld EG, and Lefrancois L: Dynamics of blood-borne CD8 memory T cell migration in vivo. Immunity 2004;20:551-562.
68. Kobayashi N, Kondo T, Takata H, Yokota S, and Takiguchi M: Functional and phenotypic analysis of human memory CD8+ T cells expressing CXCR3. J Leukoc Biol 2006;80:320-329.
69. Krawczyk CM, Shen H, and Pearce EJ: Functional plasticity in memory T helper cell responses. J Immunol 2007;178:4080-4088.
70. Kunkel EJ, and Butcher EC: Chemokines and the tissue-specific migration of lymphocytes. Immunity 2002;16:1-4.
71. Kyoizumi S, Ohara T, Kusunoki Y, Hayashi T, Koyama K, and Tsuyama N: Expression characteristics and stimulatory functions of CD43 in human CD4+ memory T cells: analysis using a monoclonal antibody to CD43 that has a novel lineage specificity. J Immunol 2004;172:7246-7253.
72. Lanzavecchia A and Sallusto F: Progressive differentiation and selection of the fittest in the immune response. Nat Rev Immunol 2002;2:982-987.
73. Lee WT, Yin X-M, and Vitetta ES: Functional and ontogenetic analysis of murine CD45Rhi and CD45Rlo CD4+ T cells. J Immunol 1990;l144:3288-3295.
74. Lefrancois L, and Marzo AL: The descent of memory T-cell subsets. Nat Rev Immunol 2006;6:618-623.
75. Lefrancois L, and Masopust D: T cell immunity in lymphoid and non-lymphoid tissues. Curr Opin Immunol 2002;14:503-508.
76. Li Q, Duan L, Estes JD, et al.: Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 2005;434:1148-1152.
77. Linsley PS, Wallace PM, Johnson J, et al.: Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 1992;257:792-795.
78. Liu F, Feuer R, Hassett DE, and Whitton JL: Peptide vaccination of mice immune to LCMV or vaccinia virus causes serious CD8 T cell-mediated, TNF-dependent immunopathology. J Clin Invest 2006;116:465-475.
79. London CA, Lodge MP, and Abbas AK: Functional responses and costimulator dependence of memory CD4+ T cells. J Immunol 2000;164:265-272.
80. Lozza L, Rivino L, Guarda G, et al.: The strength of T cell stimulation determines IL-7 responsiveness, secondary expansion, and lineage commitment of primed human CD4(+)IL-7R(hi) T cells. Eur J Immunol 2008;38:30-39.
81. Makedonas G, and Betts MR: Polyfunctional analysis of human T cell responses: importance in vaccine immunogenicity and natural infection. Springer Semin Immunopathol 2006;28:209-219.
82. Marshall DR, Turner SJ, Belz GT, et al.: Measuring the diaspora for virus-specific CD8+ T cells. Proc Natl Acad Sci USA 2001;98:6313-6318.
83. Marzo AL, Klonowski KD, Le Bon A, Borrow P, Tough DF, and Lefrancois L: Initial T cell frequency dictates memory CD8+ T cell lineage commitment. Nat Immunol 2005;6:793-799.
84. Marzo AL, Yagita H, and Lefrancois L: Cutting edge: migration to nonlymphoid tissues results in functional conversion of central to effector memory CD8 T cells. J Immunol 2007;179:36-40.
85. Masopust D, and Lefrancois L: CD8 T-cell memory: the other half of the story. Microbes Infect 2003;5:221-226.
86. Masopust D, Vezys V, Marzo AL, and Lefrancois L: Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001;291:2413-2417.
87. Masopust D, Vezys V, Usherwood EJ, et al.: Activated primary and memory CD8 T cells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin. J Immunol 2004;172:4875-4882.
88. Masopust D, Vezys V, Wherry EJ, Barber DL, and Ahmed R: Cutting edge: gut microenvironment promotes differentiation of a unique memory CD8 T cell population. J Immunol 2006;176:2079-2083.
89. McNeal MM, VanCott JL, Choi AH, et al.: CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G). J Virol 2002;76:560-568.
90. Messi M, Giacchetto I, Nagata K, Lanzavecchia A, Natoli G, and Sallusto F: Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes. Nat Immunol 2003;4:78-86.
91. Mirenda V, Jarmin SJ, David R, et al.: Physiologic and aberrant regulation of memory T-cell trafficking by the costimulatory molecule CD28. Blood 2007;109:2968-2977.
92. Moon JJ, Chu HH, Pepper M, McSorley SJ, Jameson SC, Kedl RM, and Jenkins MK: Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 2007;27:203-213.
93. Mosmann TR, and Coffman RL: TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-173.
94. Moulton VR, Bushar ND, Leeser DB, Patke DS, and Farber DL: Divergent generation of heterogeneous memory CD4 T cells. J Immunol 2006;177:869-876.
95. Moulton VR, and Farber DL: Committed to memory: lineage choices for activated T cells. Trends Immunol 2006;27:261-267.
96. Moyron-Quiroz JE, Rangel-Moreno J, Hartson L, et al.: Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs. Immunity 2006;25:643-654.
97. Ndejembi MP, Tang AL, and Farber DL: Reshaping the past: Strategies for modulating T-cell memory immune responses. Clin Immunol 2007;122:1-12.
98. Ndejembi MP, Teijaro JR, Patke DS, et al.: Control of memory CD4 T cell recall by the CD28/B7 costimulatory pathway. J Immunol 2006;177:7698-7706.
99. Neal ZC, and Splitter GA: Picornavirus-specific CD4+ T lymphocytes possessing cytolytic activity confer protection in the absence of prophylactic antibodies. J Virol 1995;69:4914-4923.
100. Ohara T, Koyama K, Kusunoki Y, Hayashi T, Tsuyama N, Kubo Y, and Kyoizumi S: Memory functions and death proneness in three CD4+CD45RO+ human T cell subsets. J Immunol 2000;169:39-48.
101. Okoye A, Meier-Schellersheim M, Brenchley JM, et al.: Progressive CD4+ central memory T cell decline results in CD4+ effector memory insufficiency and overt disease in chronic SIV infection. J Exp Med 2007;204:2171-2185.
102. Ostler T, Hussell T, Surh CD, Openshaw P, and Ehl S: Long-term persistence and reactivation of T cell memory in the lung of mice infected with respiratory syncytial virus. Eur J Immunol 2001;31:2574-2582.
103. Pahar B, Lackner AA, and Veazey RS: Intestinal double-positive CD4+CD8+ T cells are highly activated memory cells with an increased capacity to produce cytokines. Eur J Immunol 2006;36:583-592.
104. Pantaleo G, and Harari A: Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. Nat Rev Immunol 2006;6:417-423.
105. Parretta E, Cassese G, Barba P, Santoni A, Guardiola J, and Di Rosa F: CD8 cell division maintaining cytotoxic memory occurs predominantly in the bone marrow. J Immunol 2005;174:7654-7664.
106. Patke DS, and Farber DL: Modulation of memory CD4 T cell function and survival potential by altering the strength of the recall stimulus. J Immunol 2005;174:5433-5443.
107. Perarnau B, Saron MF, San Martin BR, et al.: Single H2Kb, H2Db and double H2KbDb knockout mice: peripheral CD8+ T cell repertoire and anti-lymphocytic choriomeningitis virus cytolytic responses. Eur J Immunol 1999;29:1243-1252.
108. Pober JS, Kluger MS, and Schechner JS: Human endothelial cell presentation of antigen and the homing of memory/effector T cells to skin. Ann NY Acad Sci 2001;941:12-25.
109. Pourgheysari B, Khan N, Best D, Bruton R, Nayak L, and Moss PA: The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire. J Virol 2007;81:7759-7765.
110. Richards H, Longhi MP, Wright K, Gallimore A, and Ager A: CD62L (L-selectin) down-regulation does not affect memory T cell distribution but failure to shed compromises anti-viral immunity. J Immunol 2008;180:198-206.
111. Rivino L, Messi M, Jarrossay D, Lanzavecchia A, Sallusto F, and Geginat J: Chemokine receptor expression identifies pre-T helper (Th)1, pre-Th2, and nonpolarized cells among human CD4+ central memory T cells. J Exp Med 2004;200:725-735.
112. Roberts AD, Ely KH, and Woodland DL: Differential contributions of central and effector memory T cells to recall responses. J Exp Med 2005;202:123-133.
113. Roberts AD, and Woodland DL: Cutting edge: effector memory CD8+ T cells play a prominent role in recall responses to secondary viral infection in the lung. J Immunol 2004;172:6533-6537.
114. Rogers PR, Dubey C, and Swain SL: Qualitative changes accompany memory T cell generation: faster, more effective responses at lower doses of antigen. J Immunol 2000;164:2338-2346.
115. Romero P, Zippelius A, Kurth I, et al.: Four functionally distinct populations of human effector-memory CD8+ T lymphocytes. J Immunol 2007;178:4112-4119.
116. Rose JR, Williams MB, Rott LS, Butcher EC, and Greenberg HB: Expression of the mucosal homing receptor alpha4beta7 correlates with the ability of CD8+ memory T cells to clear rotavirus infection. J Virol 1998;72:726-730.
117. Rothoeft T, Fischer K, Zawatzki S, Schulz V, Schauer U, and Korner Rettberg C: Differential response of human naive and memory/effector T cells to dendritic cells infected by respiratory syncytial virus. Clin Exp Immunol 2007;150:263-273.
118. Sallusto F, Geginat J, and Lanzavecchia A: Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004;22:745-763.
119. Sallusto F, Langenkamp A, Geginat J, and Lanzavecchia A: Functional subsets of memory T cells identified by CCR7 expression. Curr Top Microbiol Immunol 2000;251:167-171.
120. Sallusto F, Lenig D, Forster R, Lipp M, and Lanzavecchia A: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions [see comments]. Nature 1999;401:708-712.
121. Selin LK, Brehm MA, Naumov YN, Cornberg M, Kim SK, Clute SC, and Welsh RM: Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity. Immunol Rev 2006;211:164-181.
122. Selin LK, Nahill SR, and Welsh RM: Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J Exp Med 1994;179:1933-1943.
123. Selin LK, Varga SM, Wong IC, and Welsh RM: Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J Exp Med 1998;188:1705-1715.
124. Selin LK, and Welsh RM: Plasticity of T cell memory responses to viruses. Immunity 2004;20:5-16.
125. Shiao SL, McNiff JM, and Pober JS: Memory T cells and their costimulators in human allograft injury. J Immunol 2005;175:4886-4896.
126. Singh A, and Suresh M: A role for TNF in limiting the duration of CTL effector phase and magnitude of CD8 T cell memory. J Leukoc Biol 2007;82:1201-1211.
127. Slifka MK, and Whitton JL: Activated and memory CD8+ T cells can be distinguished by their cytokine profiles and phenotypic markers. J Immunol 2000;164:208-216.
128. Smiley KL, McNeal MM, Basu M, Choi AH, Clements JD, and Ward RL: Association of gamma interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G). J Virol 2007;81:3740-3748.
129. Smythies LE, Sellers M, Clements RH, et al.: Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest 2005;115:66-75.
130. Soler D, Chapman TR, Poisson LR, et al.: CCR8 expression identifies CD4 memory T cells enriched for FOXP3+ regulatory and Th2 effector lymphocytes. J Immunol 2006;177:6940-6951.
131. Song K, Rabin RL, Hill BJ, et al.: Characterization of subsets of CD4+ memory T cells reveals early branched pathways of T cell differentiation in humans. Proc Natl Acad Sci USA 2005;102:7916-7921.
132. Sprent J, and Surh CD: T cell memory. Annu Rev Immunol 2002;20:551-579.
133. Stohlman SA, Hinton DR, Parra B, Atkinson R, and Bergmann CC: CD4 T cells contribute to virus control and pathology following CNS infection by neurotropic mouse hepatitis virus. J Virol 2008;82:2130-2139
134. Stubbe M, Vanderheyde N, Goldman M, and Marchant A: Antigen-specific central memory CD4+ T lymphocytes produce multiple cytokines and proliferate in vivo in humans. J Immunol 2006;177:8185-8190.
135. Stubbe M, Vanderheyde N, Pircher H, Goldman M, and Marchant A: Characterization of a subset of antigen-specific human central memory CD4+ T lymphocytes producing effector cytokines. Eur J Immunol 2008;38:273-282.
136. Sun Y, Schmitz JE, Buzby AP, et al.: Virus-specific cellular immune correlates of survival in vaccinated monkeys after simian immunodeficiency virus challenge. J Virol 2006;80:10950-10956.
137. Swain SL, Dutton RW, and Woodland DL: T cell responses to influenza virus infection: effector and memory cells. Viral Immunol 2004;17:197-209.
138. Takata H, and Takiguchi M: Three memory subsets of human CD8+ T cells differently expressing three cytolytic effector molecules. J Immunol 2006;177:4330-4340.
139. Unsoeld H, Krautwald S, Voehringer D, Kunzendorf U, and Pircher H: Cutting edge: CCR7+ and CCR7- memory T cells do not differ in immediate effector cell function. J Immunol 2002;169:638-641.
140. Unsoeld H, and Pircher H: Complex memory T-cell phenotypes revealed by coexpression of CD62L and CCR7. J Virol 2005;79:4510-4513.
141. Usherwood EJ, Hogan RJ, Crowther G, Surman SL, Hogg TL, Altman JD, and Woodland DL: Functionally heterogeneous CD8(+) T-cell memory is induced by Sendai virus infection of mice. J Virol 1999;73:7278-7286.
142. Valujskikh A, Pantenburg B, and Heeger PS: Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice. Am J Transplant 2002;2:501-509.
143. van Faassen H, Saldanha M, Gilbertson D, Dudani R, Krishnan L, and Sad S: Reducing the stimulation of CD8+ T cells during infection with intracellular bacteria promotes differentiation primarily into a central (CD62LhighCD44high) subset. J Immunol 2005;174:5341-5350.
144. Veazey RS, Tham IC, Mansfield KG, et al.: Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo. J Virol 2000;74:57-64.
145. Verhoeven D, Sankaran S, and Dandekar S: Simian immunodeficiency virus infection induces severe loss of intestinal central memory T cells which impairs CD4+ T-cell restoration during antiretroviral therapy. J Med Primatol 2007;36:219-227.
146. Verhoeven D, Sankaran S, Silvey M, and Dandekar S: Antiviral therapy during primary SIV infection fails to prevent acute CD4+ T-cell loss in gut mucosa but enhances their rapid restoration through central memory Tcells. J Virol 2008;in press.
147. Wallace DL, and Beverley PCL: Phenotypic changes associated with activation of CD45RA+ and CD45RO+ T cells. Immunology 1990;69:460-467.
148. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, and Murphy KM: Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006;24:677-688.
149. Weaver CT, Hatton RD, Mangan PR, and Harrington LE: IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007;25:821-852.
150. Weinberger B, Lazuardi L, Weiskirchner I, et al.: Healthy aging and latent infection with CMV lead to distinct changes in CD8+ and CD4+ T-cell subsets in the elderly. Hum Immunol 2007;68:86-90.
151. Welsh RM, McNally JM, Brehm MA, and Selin LK: Consequences of cross-reactive and bystander CTL responses during viral infections. Virology 2000;270:4-8.
152. Welsh RM, and Selin LK: No one is naive: the significance of heterologous T-cell immunity. Nat Rev Immunol 2002;2:417-426.
153. Westendorf AM, Templin M, Geffers R, et al.: CD4+ T cell mediated intestinal immunity: chronic inflammation versus immune regulation. Gut 2005;54:60-69.
154. Wherry EJ, and Ahmed R: Memory CD8 T-cell differentiation during viral infection. J Virol 2004;78:5535-5545.
155. Wherry EJ, Teichgraber V, Becker TC, et al.: Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 2003;4:225-234.
156. Williams MA, and Bevan MJ: Shortening the infectious period does not alter expansion of CD8 T cells but diminishes their capacity to differentiate into memory cells. J Immunol 2004;173:6694-6702.
157. Woodland DL: Immunologic memory. Viral Immunol 2007;20:229-230.
158. Woodland DL, Hogan RJ, and Zhong W: Cellular immunity and memory to respiratory virus infections. Immunol Res 2001;24:53-67.
159. Woodland DL, and Scott I: T cell memory in the lung airways. Proc Am Thorac Soc 2005;2:126-131.
160. Xu L, Yoon H, Zhao MQ, Liu J, Ramana CV, and Enelow RI: Cutting edge: pulmonary immunopathology mediated by antigen-specific expression of TNFalpha by antiviral CD8+ T cells. J Immunol 2004;173:721-725.
161. Xu RH, Fang M, Klein-Szanto A, and Sigal LJ: Memory CD8+ T cells are gatekeepers of the lymph node draining the site of viral infection. Proc Natl Acad Sci USA 2007;104:10992-10997.
162. Yamaguchi Y, Fujio K, Shoda H, Okamoto A, Tsuno NH, Takahashi K, and Yamamoto K: IL-17B and IL-17C are associated with TNF-alpha production and contribute to the exacerbation of inflammatory arthritis. J Immunol 2007;179:7128-7136.
163. Yang J, Brook MO, Carvalho-Gaspar M, et al.: Allograft rejection mediated by memory T cells is resistant to regulation. Proc Natl Acad Sci USA 2007;104:19954-19959.
164. Yang L, Peng H, Zhu Z, et al.: Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen. J Gen Virol 2007;88:2740-2748.
165. Yuen KY, Chan PK, Peiris M, et al.: Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998;351:467-471.
166. Zammit DJ, Cauley LS, Pham QM, and Lefrancois L: Dendritic cells maximize the memory CD8 T cell response to infection. Immunity 2005;22:561-570.
167. Zammit DJ, Turner DL, Klonowski KD, Lefrancois L, and Cauley LS: Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration. Immunity 2006;24:439-449.
168. Zhai Y, Meng L, Gao F, Busuttil RW, and Kupiec-Weglinski JW: Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients. J Immunol 2002;169:4667-4673.
169. Zhang X, Dong H, Lin W, et al.: Human bone marrow: a reservoir for "enhanced effector memory" CD8+ T cells with potent recall function. J Immunol 2006;177:6730-6737.